Survivin immunoreactivity was not associated with any clinical variable: although samples of HCC with high level of Survivin were correlated with a shorter overall survival, this trend did not reach statistical significance (p = 0.39). The gene discussed is BIRC5; the disease is hepatocellular carcinoma.